EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Decreased Fecal Nicotinamide and Increased Bacterial Nicotinamidase Gene Expression in Ulcerative Colitis Patients

Keiya Aoyama iD, Ryodai Yamamura iD, Takehiko Katsurada, Tomohiro Shimizu iD, Daisuke Takahashi, Eiji Kondo, Norimasa Iwasaki, Akiko Tamakoshi, Tomoyoshi Soga iD, Shinji Fukuda, Masahiro Sonoshita iD, Naoya Sakamoto

Inflammatory Bowel Diseases · 01.10.2025 · 31 (10) · 2815-2825

DOI: 10.1093/ibd/izaf092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 13.05.2025. Verfasst von Keiya Aoyama und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Feces, Gastrointestinal Microbiome, Niacinamide. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: COI Next Generation Researchers Collaborative Research Fund, JSPS KAKENHI, AMED-CREST.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/objective Ulcerative colitis (UC) is significantly linked with gut microbiota, which is essential for maintaining gut health. Their metabolites mitigate gut inflammation and bolster barrier function. Among these metabolites, we focused on vitamin B3, which has been reported to improve the pathogenesis of UC in mice. This study aimed to compare fecal vitamin B3 and gut microbiota between non-UC and UC patients.

Methods

We assessed fecal metabolites and gut microbiota in 71 UC patients (UC group) and 72 non-UC patients (non-UC group) matched by sex and age in 10-year intervals. Fecal samples were collected and metabolites were analyzed using capillary electrophoresis time-of-flight mass spectrometry. Bacterial DNA was extracted for 16S rRNA gene sequencing. We analyzed fecal nicotinamide levels and gut microbiota composition, employing statistical adjustments for confounding factors.

Results

We found that the UC group exhibited significantly lower fecal nicotinamide levels and α-diversity (Shannon index) compared to the non-UC group. The relative abundance of bacterial genera such as Treponema, UCG-002, and Fusicatenibacter was decreased, while Sellimonas, Fournierella, and Oscillospira were increased in the UC group. Moreover, a negative correlation was observed between Sellimonas abundance and fecal nicotinamide levels in the UC group. Additionally, the UC group showed higher expression of a bacterial gene encoding nicotinamidase compared to the non-UC group.

Conclusions

These findings suggest that gut microbiota dysbiosis contributes to reduced vitamin B3 metabolism in UC patients. The study highlights the potential of replenishing vitamin B3 metabolic pathways as a novel therapeutic approach for UC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeFecesGastrointestinal MicrobiomeNiacinamideBacteriaHumansFemaleMaleAdultMiddle AgedRNA, Ribosomal, 16SCase-Control StudiesYoung Adult

Stichwörter der Autor:innen

gut microbiotainflammatory bowel diseasenicotinamideulcerative colitisvitamin B3

Substanzen

NiacinamideRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan.
  • Division of Biomedical Oncology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Department of Orthopaedic Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Center for Sports Medicine, Hokkaido University Hospital, Sapporo, Hokkaido, Japan.
  • Department of Public Health, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.

ORCID-Profile: Keiya Aoyama, Ryodai Yamamura, Tomohiro Shimizu, Tomoyoshi Soga, Masahiro Sonoshita

Förderung

  • COI Next Generation Researchers Collaborative Research Fund
  • JSPS KAKENHI
  • AMED-CREST
  • JST ERATO

Zitieren

APA

Aoyama, K., Yamamura, R., Katsurada, T., Shimizu, T., Takahashi, D., Kondo, E., Iwasaki, N., Tamakoshi, A., Soga, T., Fukuda, S., Sonoshita, M., & Sakamoto, N. (2025). Decreased Fecal Nicotinamide and Increased Bacterial Nicotinamidase Gene Expression in Ulcerative Colitis Patients. Inflammatory Bowel Diseases, 31(10), 2815-2825. https://doi.org/10.1093/ibd/izaf092

Vancouver

Aoyama K, Yamamura R, Katsurada T, Shimizu T, Takahashi D, Kondo E, et al. Decreased Fecal Nicotinamide and Increased Bacterial Nicotinamidase Gene Expression in Ulcerative Colitis Patients. Inflammatory Bowel Diseases. 2025;31(10):2815-2825. doi:10.1093/ibd/izaf092

BibTeX
@article{Aoyama2025,
  author = {Aoyama, Keiya and Yamamura, Ryodai and Katsurada, Takehiko and Shimizu, Tomohiro and Takahashi, Daisuke and Kondo, Eiji and Iwasaki, Norimasa and Tamakoshi, Akiko and Soga, Tomoyoshi and Fukuda, Shinji and Sonoshita, Masahiro and Sakamoto, Naoya},
  title = {Decreased Fecal Nicotinamide and Increased Bacterial Nicotinamidase Gene Expression in Ulcerative Colitis Patients},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  volume = {31},
  number = {10},
  pages = {2815--2825},
  doi = {10.1093/ibd/izaf092}
}
Kostenlos starten →